August 26th, 2022 Coherent Market Insights Releases

Prostate cancer treatment have multiple options and surgery is a common form of treatment for the disease. However, people at Stage III and Stage IV have not been highly benefited from this option as it has caused severe side effects like urinary incontinence, impotency and it hasn’t improved life quality in several patients. The minimally invasive surgical techniques for the treatment of prostate cancer are of different types such as brachytherapy, cryosurgery, robotic surgery, and laparoscopy.

Request Here For The Sample Copy Of The Report @ https://www.coherentmarketinsights.com/insight/request-sample/4079

Rise in number of research and development activities to find new methods is expected to augment growth of the North America and Europe minimally invasive prostate cancer surgery market during the forecast period. For instance, a team of scientists at Profound Medical in December 2019, reported efficiency of minimally invasive MRI-guided transurethral ultrasound ablation treatment at curing prostate cancer without causing so much of adverse effects.

Factors such as adverse effects of prostate cancer surgery such as impotency, urinary incontinence, and reduced life quality are likely to restrain growth of the North America and Europe minimally invasive prostate cancer surgery market over the forecast period.

Growing stringent clearance procedures on systems of high-intensity ultrasound for ablation of prostate tissue is a rising trend in the market. For instance, the U.S. Food and Drug Administration released new draft guidelines in June 2019 on clinical testing for manufacturers to conduct for such devices according to their special controls.

Key competitors in the North America and Europe minimally invasive prostate cancer surgery market are focusing on research and development activities for novel products in order to strengthen product portfolio. For instance, in Amy 2020, the U.S. Food and Drug Administration (FDA) granted approval to AngioDynamics for its investigational device application for NanoKnife irreversible electroporation study.

Request PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/4079

North America and Europe minimally invasive prostate cancer surgery market had a value of US$ 34,960.2 Mn in 2019 and is estimated to be valued at US$ 86,187.4 Mn by 2027 with a CAGR of 11.9% during 2020-2027.

The segment for Monitoring & Visualization among product types is anticipated to witness substantial growth in the North America and Europe minimally invasive prostate cancer surgery market over the forecast period with 40.5% market share due to rise in number of approvals for novel products and investment in R&D activities.

Key players active in the North America and Europe minimally invasive prostate cancer surgery market are Teleflex, Inc., Angiodynamics, Inc., Intuitive Surgical, Inc., Profound Medical, Siemens Healthcare, BSD Medical Corporation, Olympus Corporation, Medtronic Plc, and Ethicon Endo-Surgery, Inc.

In June 2018, the U.S. Food and Drug Administration granted 510(k) clearance to Edap for its Focal One device developed for ablation process of prostate tissue.

Reasons to buy this North America and Europe Minimally Invasive Prostate Cancer Surgery Market Report

◘ Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging North America and Europe Minimally Invasive Prostate Cancer Surgery Market

◘ Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging North America and Europe Minimally Invasive Prostate Cancer Surgery Market

◘ Leading company profiles reveal details of key North America and Europe Minimally Invasive Prostate Cancer Surgery Market players emerging five operations and financial performance

◘ Add weight to presentations and pitches by understanding the future growth prospects of the emerging North America and Europe Minimally Invasive Prostate Cancer Surgery Market with five year historical forecasts

◘ Compares data from North America, South America, Asia Pacific Europe and Middle East Africa, alongside individual chapters on each region

The next part also sheds light on the gap between supply and consumption. Apart from the mentioned information, growth rate of North America and Europe Minimally Invasive Prostate Cancer Surgery Market in 2028 is also explained. Additionally, type wise and application wise consumption tables and figures of North America and Europe Minimally Invasive Prostate Cancer Surgery Market are also given.

𝐁𝐮𝐲 𝐓𝐡𝐢𝐬 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 @ https://www.coherentmarketinsights.com/insight/buy-now/4079

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154, U.S. Email: sales@coherentmarketinsights.com United States of America: +1-206-701-6702 United Kingdom: +44-020-8133-4027 Japan: +050-5539-1737 India: +91-848-285-0837

Sign up and submit a press release

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.